Table 2.
HCC stage | Frequency, n = 120 | Reason for treatment noncompliance to NCCS consensus guidelines recommendations |
---|---|---|
Early Stage HCC | 13 | − 5, patient or family's decision − 3, MDTB recommended treatment outside of guidelines − 5, individual physician decision |
Locally advanced-stage HCC | 57 | − 23, patient or family's decision − 28, individual physician's decision − 3, MDTB recommended treatment outside of guidelines − 1, death before treatment initiation − 1, rapid disease progression before treatment − 1, poor tolerance of therapy |
Metastatic stage HCC | 50 | − 31, patient or family's decision − 1, MDTB recommended treatment outside of guidelines − 13, individual physician's decision − 3, rapid disease progression before treatment − 2, poor tolerance of therapy |
MDTB, multidisciplinary tumour board; HCC, hepatocellular carcinoma; NCCS, National Cancer Centre Singapore.